Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 181 entries
Sorted by: Best Match Show Resources per page
Validation of the Malay version of Diabetes Quality of Life (DQOL) Questionnaire for Adult Population with Type 2 Diabetes Mellitus.

The Malaysian journal of medical sciences : MJMS

Bujang MA, Ismail M, Hatta NKBM, Othman SH, Baharum N, Lazim SSM.
PMID: 28951693
Malays J Med Sci. 2017 Aug;24(4):86-96. doi: 10.21315/mjms2017.24.4.10. Epub 2017 Aug 18.

OBJECTIVE: We aimed to validate the Malay version of Diabetes Quality of Life (DQOL) questionnaire for Malaysian adult population with type 2 diabetes mellitus (DM).METHODS: This is a cross-sectional study to validate Malay version of DQOL among the adult...

Cite
Bujang MA, Ismail M, Hatta NKBM, et al. Validation of the Malay version of Diabetes Quality of Life (DQOL) Questionnaire for Adult Population with Type 2 Diabetes Mellitus. Malays J Med Sci. 2017;24(4):86-96doi: 10.21315/mjms2017.24.4.10.
Bujang, M. A., Ismail, M., Hatta, N. K. B. M., Othman, S. H., Baharum, N., & Lazim, S. S. M. (2017). Validation of the Malay version of Diabetes Quality of Life (DQOL) Questionnaire for Adult Population with Type 2 Diabetes Mellitus. The Malaysian journal of medical sciences : MJMS, 24(4), 86-96. https://doi.org/10.21315/mjms2017.24.4.10
Bujang, Mohamad Adam, et al. "Validation of the Malay version of Diabetes Quality of Life (DQOL) Questionnaire for Adult Population with Type 2 Diabetes Mellitus." The Malaysian journal of medical sciences : MJMS vol. 24,4 (2017): 86-96. doi: https://doi.org/10.21315/mjms2017.24.4.10
Bujang MA, Ismail M, Hatta NKBM, Othman SH, Baharum N, Lazim SSM. Validation of the Malay version of Diabetes Quality of Life (DQOL) Questionnaire for Adult Population with Type 2 Diabetes Mellitus. Malays J Med Sci. 2017 Aug;24(4):86-96. doi: 10.21315/mjms2017.24.4.10. Epub 2017 Aug 18. PMID: 28951693; PMCID: PMC5609693.
Copy Download .nbib Format: NLM
Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats.

Journal of pharmacy & bioallied sciences

Chakraborty S, Pujani M, Haque SE.
PMID: 26229360
J Pharm Bioallied Sci. 2015 Jul-Sep;7(3):233-8. doi: 10.4103/0975-7406.160037.

INTRODUCTION: Resveratrol is a natural polyphenol present mainly in grapes. It has been shown to offer strong cardio protection in animal models due to its ability to correct lipid peroxidation and maintain antioxidants level. Atorvastatin, a HMG-CoA reductase inhibitor,...

Cite
Chakraborty S, Pujani M, Haque SE. Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats. J Pharm Bioallied Sci. 2015;7(3):233-8doi: 10.4103/0975-7406.160037.
Chakraborty, S., Pujani, M., & Haque, S. E. (2015). Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats. Journal of pharmacy & bioallied sciences, 7(3), 233-8. https://doi.org/10.4103/0975-7406.160037
Chakraborty, Songjukta, et al. "Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats." Journal of pharmacy & bioallied sciences vol. 7,3 (2015): 233-8. doi: https://doi.org/10.4103/0975-7406.160037
Chakraborty S, Pujani M, Haque SE. Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats. J Pharm Bioallied Sci. 2015 Jul-Sep;7(3):233-8. doi: 10.4103/0975-7406.160037. PMID: 26229360; PMCID: PMC4517328.
Copy Download .nbib Format: NLM
Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant?.

ERJ open research

Man WD, Puhan MA, Harrison SL, Jordan RE, Quint JK, Singh SJ.
PMID: 27730157
ERJ Open Res. 2015 Oct 06;1(2). doi: 10.1183/23120541.00050-2015. eCollection 2015 Oct.

Hospitalisations for severe exacerbations of chronic obstructive pulmonary disease are associated with significant physical and psychological consequences including an increase in symptom severity, severe reductions in physical activity, a deleterious effect on skeletal muscle, impaired exercise tolerance/ability to self-care,...

Cite
Man WD, Puhan MA, Harrison SL, et al. Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant?. ERJ Open Res. 2015;1(2)doi: 10.1183/23120541.00050-2015.
Man, W. D., Puhan, M. A., Harrison, S. L., Jordan, R. E., Quint, J. K., & Singh, S. J. (2015). Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant?. ERJ open research, 1(2), . https://doi.org/10.1183/23120541.00050-2015
Man, William D-C, et al. "Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant?." ERJ open research vol. 1,2 (2015). doi: https://doi.org/10.1183/23120541.00050-2015
Man WD, Puhan MA, Harrison SL, Jordan RE, Quint JK, Singh SJ. Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant?. ERJ Open Res. 2015 Oct 06;1(2). doi: 10.1183/23120541.00050-2015. eCollection 2015 Oct. PMID: 27730157; PMCID: PMC5005122.
Copy Download .nbib Format: NLM
Large and tunable lateral shifts in one-dimensional PT-symmetric layered structures.

Optics express

Ma P, Gao L.
PMID: 28468349
Opt Express. 2017 May 01;25(9):9676-9688. doi: 10.1364/OE.25.009676.

The lateral shifts of the wave reflected and transmitted from PT-symmetric one-dimensional multilayer-structures are investigated near the coherent-perfect-absorption (CPA)-laser point and the exceptional points. We predict that at the CPA-Laser point, the reflections from both sides and transmission as...

Cite
Ma P, Gao L. Large and tunable lateral shifts in one-dimensional PT-symmetric layered structures. Opt Express. 2017;25(9):9676-9688doi: 10.1364/OE.25.009676.
Ma, P., & Gao, L. (2017). Large and tunable lateral shifts in one-dimensional PT-symmetric layered structures. Optics express, 25(9), 9676-9688. https://doi.org/10.1364/OE.25.009676
Ma, Pujuan, and Gao, Lei. "Large and tunable lateral shifts in one-dimensional PT-symmetric layered structures." Optics express vol. 25,9 (2017): 9676-9688. doi: https://doi.org/10.1364/OE.25.009676
Ma P, Gao L. Large and tunable lateral shifts in one-dimensional PT-symmetric layered structures. Opt Express. 2017 May 01;25(9):9676-9688. doi: 10.1364/OE.25.009676. PMID: 28468349.
Copy Download .nbib Format: NLM
The unusual nested carcinoma of the renal pelvis.

Urology annals

Agarwal K, Madan NK, Pujani M, Rao M.
PMID: 24311913
Urol Ann. 2013 Oct;5(4):287-90. doi: 10.4103/0974-7796.120312.

Invasive urothelial carcinoma has a potential to show divergent differentiation. Several uncommon morphological variants have been described in the recent past. One such rare type is the nested variant of urothelial carcinoma. Most of the published reports depict occurrence...

Cite
Agarwal K, Madan NK, Pujani M, et al. The unusual nested carcinoma of the renal pelvis. Urol Ann. 2013;5(4):287-90doi: 10.4103/0974-7796.120312.
Agarwal, K., Madan, N. K., Pujani, M., & Rao, M. (2013). The unusual nested carcinoma of the renal pelvis. Urology annals, 5(4), 287-90. https://doi.org/10.4103/0974-7796.120312
Agarwal, Kiran, et al. "The unusual nested carcinoma of the renal pelvis." Urology annals vol. 5,4 (2013): 287-90. doi: https://doi.org/10.4103/0974-7796.120312
Agarwal K, Madan NK, Pujani M, Rao M. The unusual nested carcinoma of the renal pelvis. Urol Ann. 2013 Oct;5(4):287-90. doi: 10.4103/0974-7796.120312. PMID: 24311913; PMCID: PMC3835991.
Copy Download .nbib Format: NLM
Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review.

Current controlled trials in cardiovascular medicine

Scharplatz M, Puhan MA, Steurer J, Perna A, Bachmann LM.
PMID: 16242049
Curr Control Trials Cardiovasc Med. 2005 Oct 24;6:16. doi: 10.1186/1468-6708-6-16.

BACKGROUND: Pharmacogenetic testing to individualize ACE inhibitor therapy remains controversial. We conducted a systematic review to assess the effect modification of the insertion/deletion (I/D) polymorphism of the ACE gene on any outcome in patients treated with ACE inhibitors for...

Cite
Scharplatz M, Puhan MA, Steurer J, et al. Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review. Curr Control Trials Cardiovasc Med. 2005;6:16doi: 10.1186/1468-6708-6-16.
Scharplatz, M., Puhan, M. A., Steurer, J., Perna, A., & Bachmann, L. M. (2005). Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review. Current controlled trials in cardiovascular medicine, 616. https://doi.org/10.1186/1468-6708-6-16
Scharplatz, Madlaina, et al. "Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review." Current controlled trials in cardiovascular medicine vol. 6 (2005): 16. doi: https://doi.org/10.1186/1468-6708-6-16
Scharplatz M, Puhan MA, Steurer J, Perna A, Bachmann LM. Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review. Curr Control Trials Cardiovasc Med. 2005 Oct 24;6:16. doi: 10.1186/1468-6708-6-16. PMID: 16242049; PMCID: PMC1283147.
Copy Download .nbib Format: NLM
[From "evidence" to "knowledge-based medicine"].

Therapeutische Umschau. Revue therapeutique

Bachmann LM, Puhan MA, Steurer J.
PMID: 18581911
Ther Umsch. 2007 Dec;64(12):657-8. doi: 10.1024/0040-5930.64.12.657.

No abstract available.

Cite
Bachmann LM, Puhan MA, Steurer J. Von der "Evidenze"- zur "Wissens- basierten Medizin". [From "evidence" to "knowledge-based medicine"]. Ther Umsch. 2007;64(12):657-8doi: 10.1024/0040-5930.64.12.657.
Bachmann, L. M., Puhan, M. A., & Steurer, J. (2007). Von der "Evidenze"- zur "Wissens- basierten Medizin". [From "evidence" to "knowledge-based medicine"]. Therapeutische Umschau. Revue therapeutique, 64(12), 657-8. https://doi.org/10.1024/0040-5930.64.12.657
Bachmann, Lucas M, et al. "Von der "Evidenze"- zur "Wissens- basierten Medizin"." [From "evidence" to "knowledge-based medicine"]. Therapeutische Umschau. Revue therapeutique vol. 64,12 (2007): 657-8. doi: https://doi.org/10.1024/0040-5930.64.12.657
Bachmann LM, Puhan MA, Steurer J. Von der "Evidenze"- zur "Wissens- basierten Medizin". [From "evidence" to "knowledge-based medicine"]. Ther Umsch. 2007 Dec;64(12):657-8. doi: 10.1024/0040-5930.64.12.657. German. PMID: 18581911.
Copy Download .nbib Format: NLM
Self-efficacy instruments for patients with chronic diseases suffer from methodological limitations--a systematic review.

Health and quality of life outcomes

Frei A, Svarin A, Steurer-Stey C, Puhan MA.
PMID: 19781095
Health Qual Life Outcomes. 2009 Sep 26;7:86. doi: 10.1186/1477-7525-7-86.

BACKGROUND: Measurement of self-efficacy requires carefully developed and validated instruments. It is currently unclear whether available self-efficacy instruments for chronic diseases fulfill these requirements. Our aim was to systematically identify all existing self-efficacy scales for five major chronic diseases...

Cite
Frei A, Svarin A, Steurer-Stey C, et al. Self-efficacy instruments for patients with chronic diseases suffer from methodological limitations--a systematic review. Health Qual Life Outcomes. 2009;7:86doi: 10.1186/1477-7525-7-86.
Frei, A., Svarin, A., Steurer-Stey, C., & Puhan, M. A. (2009). Self-efficacy instruments for patients with chronic diseases suffer from methodological limitations--a systematic review. Health and quality of life outcomes, 786. https://doi.org/10.1186/1477-7525-7-86
Frei, Anja, et al. "Self-efficacy instruments for patients with chronic diseases suffer from methodological limitations--a systematic review." Health and quality of life outcomes vol. 7 (2009): 86. doi: https://doi.org/10.1186/1477-7525-7-86
Frei A, Svarin A, Steurer-Stey C, Puhan MA. Self-efficacy instruments for patients with chronic diseases suffer from methodological limitations--a systematic review. Health Qual Life Outcomes. 2009 Sep 26;7:86. doi: 10.1186/1477-7525-7-86. PMID: 19781095; PMCID: PMC2761851.
Copy Download .nbib Format: NLM
Increased hematogones in an infant with bicytopenia and leucocytosis:a case report.

Cases journal

Agarwal K, Aggarwal M, Aggarwal VK, Pujani M, Nain M.
PMID: 20202210
Cases J. 2010 Mar 04;3:75. doi: 10.1186/1757-1626-3-75.

Hematogones are the normal bone marrow constituents of bone marrow in children and their number decreases with age. As hematogones can resemble malignant lymphoblasts by their morphologic features and by expression of an immature B-cell phenotype, an accurate distinction...

Cite
Agarwal K, Aggarwal M, Aggarwal VK, et al. Increased hematogones in an infant with bicytopenia and leucocytosis:a case report. Cases J. 2010;3:75doi: 10.1186/1757-1626-3-75.
Agarwal, K., Aggarwal, M., Aggarwal, V. K., Pujani, M., & Nain, M. (2010). Increased hematogones in an infant with bicytopenia and leucocytosis:a case report. Cases journal, 375. https://doi.org/10.1186/1757-1626-3-75
Agarwal, Kiran, et al. "Increased hematogones in an infant with bicytopenia and leucocytosis:a case report." Cases journal vol. 3 (2010): 75. doi: https://doi.org/10.1186/1757-1626-3-75
Agarwal K, Aggarwal M, Aggarwal VK, Pujani M, Nain M. Increased hematogones in an infant with bicytopenia and leucocytosis:a case report. Cases J. 2010 Mar 04;3:75. doi: 10.1186/1757-1626-3-75. PMID: 20202210; PMCID: PMC2844362.
Copy Download .nbib Format: NLM
Use of rapid detection tests to prevent transfusion-transmitted malaria in India.

Asian journal of transfusion science

Bahadur S, Pujani M, Jain M.
PMID: 20859522
Asian J Transfus Sci. 2010 Jul;4(2):140-1. doi: 10.4103/0973-6247.67033.

No abstract available.

Cite
Bahadur S, Pujani M, Jain M. Use of rapid detection tests to prevent transfusion-transmitted malaria in India. Asian J Transfus Sci. 2010;4(2):140-1doi: 10.4103/0973-6247.67033.
Bahadur, S., Pujani, M., & Jain, M. (2010). Use of rapid detection tests to prevent transfusion-transmitted malaria in India. Asian journal of transfusion science, 4(2), 140-1. https://doi.org/10.4103/0973-6247.67033
Bahadur, Shalini, et al. "Use of rapid detection tests to prevent transfusion-transmitted malaria in India." Asian journal of transfusion science vol. 4,2 (2010): 140-1. doi: https://doi.org/10.4103/0973-6247.67033
Bahadur S, Pujani M, Jain M. Use of rapid detection tests to prevent transfusion-transmitted malaria in India. Asian J Transfus Sci. 2010 Jul;4(2):140-1. doi: 10.4103/0973-6247.67033. PMID: 20859522; PMCID: PMC2937298.
Copy Download .nbib Format: NLM
Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis.

Clinical epidemiology

Mills EJ, Druyts E, Ghement I, Puhan MA.
PMID: 21487451
Clin Epidemiol. 2011 Mar 28;3:107-29. doi: 10.2147/CLEP.S16235.

BACKGROUND: Most patients with moderate and severe chronic obstructive pulmonary disease (COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however, unclear if and what drug treatments should be added to LABAs to reduce exacerbations, which is an...

Cite
Mills EJ, Druyts E, Ghement I, et al. Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis. Clin Epidemiol. 2011;3:107-29doi: 10.2147/CLEP.S16235.
Mills, E. J., Druyts, E., Ghement, I., & Puhan, M. A. (2011). Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis. Clinical epidemiology, 3107-29. https://doi.org/10.2147/CLEP.S16235
Mills, Edward J, et al. "Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis." Clinical epidemiology vol. 3 (2011): 107-29. doi: https://doi.org/10.2147/CLEP.S16235
Mills EJ, Druyts E, Ghement I, Puhan MA. Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis. Clin Epidemiol. 2011 Mar 28;3:107-29. doi: 10.2147/CLEP.S16235. PMID: 21487451; PMCID: PMC3072154.
Copy Download .nbib Format: NLM
Juvenile myelomonocytic leukemia.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Sethi N, Kushwaha S, Dhingra B, Pujani M, Chandra J, Shukla S.
PMID: 24426365
Indian J Hematol Blood Transfus. 2013 Sep;29(3):164-6. doi: 10.1007/s12288-012-0164-9. Epub 2012 Jun 10.

Juvenile myelomonocytic leukemia (JMML) is a rare fatal hematopoietic disorder of early childhood. We are presenting a case of 9-month-old female child who was admitted with abdominal distension, irritability, and hepatosplenomegaly. Peripheral blood film examination showed leukoerythroblastosis with leukocytosis,...

Cite
Sethi N, Kushwaha S, Dhingra B, et al. Juvenile myelomonocytic leukemia. Indian J Hematol Blood Transfus. 2012;29(3):164-6doi: 10.1007/s12288-012-0164-9.
Sethi, N., Kushwaha, S., Dhingra, B., Pujani, M., Chandra, J., & Shukla, S. (2013). Juvenile myelomonocytic leukemia. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 29(3), 164-6. https://doi.org/10.1007/s12288-012-0164-9
Sethi, Neha, et al. "Juvenile myelomonocytic leukemia." Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion vol. 29,3 (2013): 164-6. doi: https://doi.org/10.1007/s12288-012-0164-9
Sethi N, Kushwaha S, Dhingra B, Pujani M, Chandra J, Shukla S. Juvenile myelomonocytic leukemia. Indian J Hematol Blood Transfus. 2013 Sep;29(3):164-6. doi: 10.1007/s12288-012-0164-9. Epub 2012 Jun 10. PMID: 24426365; PMCID: PMC3710560.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 181 entries